Global Research Trends

Wednesday, 31 March 2021

Small Cell Lung Cancer Therapeutics Market Opportunity Analysis-2026

Small Cell Lung Cancer Therapeutics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

Small Cell Lung Cancer (SCLC) is malignant form of cancer arising within the lungs. SCLC is characterized by high growth rate, shorter doubling time than the non-small cell lung tumors. SCLC is more responsive to chemotherapy than NSCLC. Small cell lung cancer is highly associated with tobacco, unhealthy food, alcohol, HIV infected, chronic infections or related family history, and physical inactivity. The decrease in smoking is reflected as the substantial decrease in the incidence of SCLC. The symptoms include dyspnea, blood in sputum, weight loss, cough, and debility.

Global rise in number of cancer cases expected to support the growth of small cell lung cancer therapeutics market in the near future

According to the American Cancer Society Statistics in 2016, maximum cases of SCLC occur in individuals aged 60-80 years with an estimated global death rate being 30,000 per year. Also, according to the World Health Organization (WHO), lung cancer is the second most prevailing cancer in men and women causing 1.59 million deaths in 2012. The rising prevalence of lung cancer, rise in unhealthy lifestyle, the launch of innovative radiation therapies, and premium priced drugs are the major factors driving the growth of lung cancer therapeutics market.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/799

Additionally, rising demand for targeted therapies and platinum-based chemotherapies is likely to have an optimistic impact on the small lung cancer therapeutics market in the forecast period. Also, increasing diagnostic facilities by the government, provision of guidelines to cancer patients by International Healthcare Organizations are the major factors contributing to the rising of small cell lung cancer market. However, expensive treatments, lack of awareness leading to late diagnosis are the major factors restraining the small cell lung cancer market growth.

Enhanced health care dynamics to boost the Asia Pacific small cell lung cancer market

Regional segmentation of small cell lung cancer therapeutics market by Coherent Market Insights comprises of North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. According to the American Cancer Society Statistics in 2017, around 222,500 cases of lung cancer were diagnosed with 116,990 prevailing in men and 105,510 in women, where small cell lung cancer accounts for 15 percent of lung cancers in the U.S. North America is expected to dominate the market owing to the high developed regions, improved healthcare setup, and growing awareness about healthcare. Asia Pacific is expected to drive the growth of SCLC market in the forecast period owing to the growing awareness of health care, government funding, and the presence of medical requirements for cancer therapeutics in the emerging economies such as India and China.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/small-cell-lung-cancer-therapeutics-market-799

Key players in the Small Cell Lung Cancer Therapeutics Market

Key players operating the small cell lung cancer therapeutics market include Bristol-Myers Squibb, GlaxoSmithKline, Menarini, Sanofi, and ZIOPHARM Oncology.

Platinum derivatives segment accounts for highest revenue share owing to the higher metastasis control rate

The global small cell lung cancer therapeutics market is segmented on the basis of drug therapy, and distribution channel.

On the basis of drug therapy, the global small cell lung cancer therapeutics market is segmented into:

Targeted Therapy Drugs

Immunotherapy Drugs

Platinum Derivatives

On the basis of distribution channel, the global small cell lung cancer therapeutics market is segmented into:

Hospital Pharmacies

Retail and Online Pharmacies

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/799

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name: Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US : +1-206-701-6702

UK : +44-020-8133-4027

JAPAN : +050-5539-1737

Equine Healthcare Market Size, Trends, Shares, Insights and Forecast – 2018-2026

Equine Healthcare Market, By Diagnostic Products (Pregnancy and Gestation Diagnostic, Genotyping Analysis), Therapeutic Products (Dopamine Agonists, Vaccines, Anti-Bacterial, Anti-Protozoal, Anti-Viral, Laxatives, Anti-Inflammatory), and Supplements (Performance and Protection Supplements) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

Equine Healthcare refers to the activities and practices aimed for the maintenance of horses. Equine healthcare offers the veterinary services intended for treating horses to enhance their quality of life, develop quality animal food and increase lifespan. The total equine population is directly proportional to the quality of equine healthcare. Equine healthcare includes a number of activities including diagnosis, therapies and supplements for maintaining internal health of horses. The diagnostic products help detect bacteria, viruses and antibodies, therapeutic products helps to treat disease through vaccination and supplement products helps in maintaining specific requirements.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/835

High return on investment and rise in genotypic analyzers is expected to lead the market expansion

Equine veterinary practice is expected to be a high overhead owing to prevent the rising diseases like influenza virus, herpes virus, west nile virus and encephalomyelitis, where the cost for global vaccination is estimated to be around 30 million dollars by the Euro Surveillance Journal in 2016. Rising investments and popularity in alternative forms of gambling like horse racing, online gaming, betting, competitive riding, high return on investment and leisure is expected to drive the global equine healthcare market. The growth and rising demand for gestation diagnosis products, increasing urine test kits, ultrasound devices and supplement products will boost the global equine healthcare market. Additionally, the growing initiatives by equine healthcare organizations to develop drugs for various diseases is expected to give impetus to the equine healthcare market. The non-invasive test kits are largely preferred by the veterinarians owing to the easy usage and affordability.

Asia Pacific market is expected to show positive growth owing to the import of quality of quality breeds and their maintenance

Regional segmentation of the equine healthcare market by Coherent Market Insights comprises of North America, Europe, Asia Pacific, Latin America, Middle East and Africa. According to the study conducted by the American Horse Council in 2004, U.S. has 9.2 million horses with $39 billion direct economic impact. Also, a total 22,849 horses were imported into the U.S. in 2013, thereby increasing the demand of equine healthcare in North America.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/equine-healthcare-market-835

The Australian market is among the leading horse breeding countries of Asia Pacific, hence contributing to the drastically increasing demand for healthcare products in Asia Pacific. Additionally, the maintenance of race-horse breeds by the rising investments from China by specific supplements, therapeutic and protection products drive the growth of Asia Pacific market.

Animal-health innovation driven acquisition broadens global equine healthcare market

Key players operating the equine healthcare market include Affymetrix Inc., Boehringer Ingelheim, Merck, Bayer Health Care and Elanco Animal Health. The agreement of Sanofi with Bayer equine health to launch a variety of products to prevent gastric ulcer syndrome, westnile virus, equine influenza and rabies in horses. The launch of updated equine influenza vaccine ProteqFlu by Merial broadens the portfolio of leading products. Other prominent Vendors include Vetoquinol, Novartis Animal Health, Ceva Holdings and Signostics.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/835

About Coherent Market Insights:

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name: Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US : +1-206-701-6702

UK : +44-020-8133-4027

JAPAN : +050-5539-1737

EClinical Solutions Market To Reach Beyond US$ 8.5 Billion By 2025 - Coherent Market Insights

The Global eClinical Solutions Market, by Deployment (Web-based, Cloud-based, and Licensed Enterprise), by Product Type (Electronic Data Capture, Electronic Clinical Outcome Assessment, Clinical Data Management System, Clinical Trial Management System, Clinical Analytics Platform, Randomization and Trial Supply Management, Electronic Trial Master File, and Others), by End User (Pharmaceutical and Biopharmaceutical Companies, Hospitals, Consulting Servicing Companies, Research Organizations, and Medical device Manufacturers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 3.5 billion in 2017 and is projected to exhibit a CAGR of 11.2% over the forecast period (2018 – 2026). The eClinical solutions market is expected to gain significant traction, due to increasing R&D by biotechnology and pharmaceutical companies.

Increasing R&D by biotechnology and pharmaceutical companies is expected to drive growth of the market Pharmaceutical and medical device companies face a number of challenges to commercialize existing and developing new products, such as patent expiry, competitive pricing pressure, and rising regulatory burden imposed due to increasing clinical trial complexity, development costs, and data volumes. The risks and costs associated with developing new treatments, mainly related to drug trials continue to increase. All these factors collectively increase the demand for eClinical solutions software. eClinical solutions software reduce drug development costs and improve efficiency by streamlining and automating the clinical trial process, and optimizing return on investment in new drug development. Electronic data capture (EDC) and clinical trial management systems (CTMS) are the most prominent eClinical solutions software. This software allow individuals to manage increasing data volumes while aiding the flexibility and speed required to execute emerging trial concepts that offer more effective commercialization. A CTMS can improve the management of the drug development process by providing a single, centralized system to manage operational and administrative activities and a real-time view of trial data that can be shared across the organization. However, high implementation cost of software, lack of skilled professional, data privacy issues, and low awareness about the software are the major factors hampering eClinical solutions market growth.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/782

Browse 45 Market Data Tables and 30 Figures spread through 200 Pages and in-depth TOC on “eClinical Solutions Market, by Deployment (Web-based, Cloud-based, and Licensed Enterprise), by Product (Electronic Data Capture, Electronic Clinical Outcome Assessment, Clinical Data Management System, Clinical Trial Management System, Clinical Analytics Platform, Randomization and Trial Supply Management, Electronic Trial Master File, and Others), by End User (Pharmaceutical and Biopharmaceutical companies, Hospitals, Consulting Servicing Companies, Research Organizations, and Medical device Manufacturers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026”

Key industry players operating the eClinical solutions market include BioClinica Inc., CRF Health, DATATRAK International Inc., eClinical Solutions Inc., MaxisIT Inc., Medidata Solutions Inc., Merge Healthcare Inc., OmniComm Systems Inc., Oracle Co., and PAREXEL International Co. Major industry players are adopting strategies such as product enhancement, partnerships, and agreements for new product development strategies to sustain and progress in eClinical solutions market. For instance, in 2018, Medidata and eClinical Solutions LLC expanded their technology partnership to further enhance clinical trial processes and help life sciences researchers deliver new therapies to patients with the adoption of Rave Imaging. Companies such as Veeva Systems, Oracle, and Medidata Solutions are offering integrated and unified eClinical solution software to improve trial efficiency and compliance processes across the R&D value chain.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/eclinical-solutions-market-782

Key Takeaways of the eClinical Solutions Market:

The global eClinical solutions market is expected to exhibit a CAGR of 11.2% over the forecast period, owing to growing adoption of software solutions during clinical research and rising government funding to support clinical trials.

Among deployment types, the cloud-based segment is estimated to hold the dominant position, as it is ideal for complex and multisite clinical studies

Among product types, the clinical data management system (CDMS) is estimated to hold major share due to its high quality, reliable, and statistically sound data

Among end users, pharmaceutical and biopharmaceutical companies segment holds a dominant position in the eClinical solutions market, owing to increasing usage of software for drug development

Asia Pacific eClinical solutions market is expected to exhibit significant growth, owing to increasing number of clinical trials being performed.

Key players operating in the global eClinical Solutions software market include BioClinica Inc., CRF Health, DATATRAK International Inc., eClinical Solutions Inc., MaxisIT Inc., Medidata Solutions Inc., Merge Healthcare Inc., OmniComm Systems Inc., Oracle Co., and PAREXEL International Co.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/782

About Coherent Market Insights:

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name: Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US : +1-206-701-6702

UK : +44-020-8133-4027

JAPAN : +050-5539-1737

Implantable Medical Devices Market Size Share Trends Forecast 2026

Implantable Medical Devices Market By Material (Metallic, Ceramic, Polymers, Natural), Product Type (Orthopedic Implants, Dental Implants, Breast Implants, Cardiovascular Implants, Intraocular lens, and Others) and End User (Hospitals, Ambulatory Surgical Centers, and Others) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

The implantable medical devices are man-made devices that are placed inside or on the surface of the body to replace a missing biological structure or to support a damaged biological structure and to enhance an existing biological structure. The implantable medical devices are helping many patients to improve their quality of life through surgical procedures The implants can be used in different body parts for numerous applications such as pacemakers, orthopedics, cardiovascular stents, neural prosthetics or drug delivery system, and defibrillators.. The surface of implantable medical devices is made up of biomedical materials such as titanium, silicone, or some other material depending upon the desired compatibility and application. Implantable medical devices can be removed when they are no longer needed or they can be placed permanently.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/836

Technological advancements in cardiac implant to drive the implantable medical devices market

New technology in the implantable medical devices with various benefits is the major factor driving the growth of the market. For instance, novel technology of patient specific implants using 3D technology and sculptural CAD, have numerous benefits over off-the-implants. Development of next generation devices, upsurge in regulatory approval for clinical trials, rise in neurological disorders in geriatric population, and improved clinical outcome are some of the other important factors that is helping in fuelling the growth of implantable medical devices market. The demand of implantable medical devices also increasing due to lack of alternative treatments for many severe disorders and injuries. The ability of implantable medical devices to reduce the treatment cost for many chronic disorders is expected to enhance the growth of implantable medical devices market. However, the implantable medical devices market restraints due to the price pressure from insurance providers and government as they have tighten control over implantation costs.

Strong healthcare infrastructure and technological advancements are responsible for the growth of North America

Regional segmentation of implantable medical devices market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, Africa, and Middle East. North America dominates in the implantable medical devices market owing to the factors such as strong healthcare infrastructure, supportive reimbursement, rising geriatric population, awareness about medical assistance, technological advancements, and high purchasing power.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/implantable-medical-devices-market-836

Lack of alternative treatments for many chronic disorders and injuries are also helping the growth of implantable medical devices market in North America. Increase in investment by government for healthcare sector, unmet medical needs, huge population base, are the major factors that might fuel the growth of the implantable medical devices market in Asia-Pacific.

The cost effective and technologically efficient medical devices are helping the industry players to strengthen their position in implantable medical devices market

Key drivers operating the implantable medical devices market includes Abbott Laboratories, Boston scientific Corporation, Johnson & Johnson, Dentsply Sirona, Medtronic plc, Smith & Nephew plc, Stryker Corporation, Terumo Corporation, and Zimmer Biomet Holdings. The major players in the implantable medical devices market have improved manufacturing techniques, upgraded the current set of products to sustain in the highly competitive implantable medical devices market. Companies have launched cost-effective and technologically advanced medical devices to hold the position in the implantable medical devices market. For instance, the Micra TPS, world’s smallest pacemaker by Medtronic plc received U.S. FDA approval and CE mark approval in April 2015 that can be implanted directly into the heart with the help of a catheter.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/836

About Coherent Market Insights:

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name: Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US : +1-206-701-6702

UK : +44-020-8133-4027

JAPAN : +050-5539-1737

Organ Transplant Market Size, Share, Outlook, and Opportunity Analysis, 2018– 2026

Technological advancements in transplantation procedures and established healthcare sector is fueling growth of organ transplant market

Regional segmentation of Organ Transplant Market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Africa, and Middle East. North America and Europe region holds the maximum share in the organ transplant market, owing to success of organ transplant surgeries and technological advancements in medical surgeries and drugs involved in transplantation. For instance in May 2016, Immucor, Inc., a global leader in transfusion and transplantation diagnostics, launched its kidney Solid Organ Response Test, kSORT. It is a molecular gene expression assay that measures a kidney recipient’s immune response to predict organ rejection and graft injury.

Organ transplantation is the surgical operation carried out for replacement of damaged or not functional organ of an individual. Donated organ are obtained from living donor, deceased donor or from an animal. Whereas in some cases an artificial organ is used for the transplantation procedure. The most common organ transplant includes kidney, heart, liver, pancreas, lung, and intestine. Double organ transplantation is also possible such as kidney and pancreas transplant and heart and lungs transplant.

Increasing number of population suffering from organ failure is driving the growth of organ transplant market

According to World Health Organization (WHO) Global Observatory on Donation and Transplantation in 2014, an estimated 119,873 organs were transplanted annually. Moreover, increasing number of chronic diseases leading to organ failure and habits such as smoking and drinking are further leading to organ disability, which is fueling growth of organ transplant market.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/838

According to Health Resources and Services Administration, till May 2017, there were around 117,829 patients waiting for organ transplants in the U.S., among them about 97,610 were waiting for kidney transplants. However, only 11,061 transplant procedures were performed from January to April 2017. Increasing number of population awaiting for organ transplant and increase in mortality rate due to the inadequate organ for transplantation might create opportunities in the organ transplant market.

Furthermore, refinement and improvement in surgical techniques and treatment strategies that are helping to increase survival rate, launch of new anti-infective and immunosuppression techniques contributing to the lower risk of organ rejection after transplantation, and the development of organ preservation and organ procurements are some of the factors fueling growth of the market. For instance, in September 2015, Arthrex Inc. launched ArthroFlex Acellular Dermal Matrix, a new orthobiologic product that is intended for use in capsular reconstruction. This product allows retention of its growth factors and native collagen scaffold and elastin allows transplant to be successfully incorporated into the receiver. However, high cost of transplantation, stringent ethical policies, lack of reimbursement, organ trafficking, and low supply of organs are some of the factors restraining growth of the organ transplant market.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/organ-transplant-market-838

Increasing awareness regarding organ donation is expected to fuel growth of organ transplant market over the forecast period

Market players rely on organ donation, which is collected, stored, and distributed by them. Increasing awareness regarding organ donation is expected to create opportunities for the industry players. However, factors such as proximity to key suppliers, understand the government policies, and get access to volunteer labor are important factors for market players to maintain leading position in organ transplant market.

Key players operating in organ transplant market include Organogenesis Incorporated, Terumo Co., OrganOX, Transplant Biomedical, Preservation solution, TransMedic, WorldHeart Co., Waters Medical systems, and Jarvik Heart Incorporated.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/838

About Coherent Market Insights:

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name: Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US : +1-206-701-6702

UK : +44-020-8133-4027

JAPAN : +050-5539-1737

Tuesday, 30 March 2021

Medical Non-woven Disposables Market Size, Trends, Shares, Insights and Forecast – 2018-2026

Increasing prevalence of hospital acquired infections and improving hygienic habits among people to favor growth of the medical non-woven disposables market

Increasing prevalence of hospital acquired infections is one of the major factors driving growth of the Medical Non-Woven Disposables Market. According to Centers for Disease Control and Prevention, in 2014, around 722,000 people contracted HAIs in acute care hospitals and around 75,000 patients suffering from HAIs died during hospitalization in the U.S. European Centre for Disease Prevention and Control, 2016, reported that from around 87337 patients admitted in the ICU for over two days, around 6995 patients were recorded with at least one HAI. Furthermore, CDC and the Association of State and Territorial Health Officials (ASTHO) have collaborated since July 2010, to ensure funding for basic elements of HAI program infrastructure at the federal, state, and local levels. Growing geriatric population has increased the demand for medical non-woven disposables, in turn, boosting growth of the market. Growing awareness regarding improved hygienic habits among the populace and introduction of new products in the incontinence segment are expected to fuel grow of the medical non-woven disposables market in the near future. High demand for surgical products in developed countries, has fueled growth of the incontinence and surgical product segments, in turn creating immense opportunities for growth of the global medical non-woven disposables market.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/888

Healthcare workers are exposed to infected liquid droplets and aerosols that possess the risk of transmitting diseases such as hospital acquired infections (HSIs) and surgical site infections (SSIs). To avoid susceptibility of such contamination, healthcare workers use surgical face masks, gloves, gowns, caps, and shoe covers, which are produced by fabric foaming technology such as woven, non-woven and knitted. Non-woven surgical fabrics have been adopted by most hospitals, as they are disposable in nature. Such materials have been developed due to advancements in technology over the recent past. Non-woven fabric forming technology is less costly than woven and knitted technology. The materials used for non-woven sheets include polypropylene, polyester, polycarbonate, polyethylene, and polystyrene. The filtration process of non-woven fabrics has various advantages over woven and knitted fabrics such as its higher bacterial filtration efficiency, higher air permeability, no yarn slippage, lesser contamination risk , and lower manufacturing cost.

Non-woven disposable products offers opportunities for favorable growth of the medical non-woven disposables market. Over the past decades, demand for polymeric nanofibers has tremendously increased, owing to its very large surface area to volume ratio. This exceptional property is suitable for application in medical textile products such as drug delivery systems, surgical face masks, and wound dressing.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/medical-non-woven-disposables-market-888

Demand for technology offering high absorbent capacity and antimicrobial properties to help reduce chances of cross-contamination, is increasing in the manufacturing of non-woven fabrics. Microencapsulation technology offers immense opportunities to improve properties of medical textile. Suspension of microcapsule is formulated in the development of non-woven textile with prolonged antimicrobial activity. The textile is then impregnated with microcapsules that are pressure-sensitive, which release the active ingredient upon pressure.

Momentive performance material, in 2011, launched NuWet 550 Hydrophilic silicone finish for non-woven medical disposables, it gives a long-lasting hydrophilic finish to non-woven fabrics such as diapers, surgical wipes. Silicone finish is employed in the medical industry help minimize the migration of water to unwanted areas during surgical processes.

Major key players operating in the medical non-woven disposables market include Kimberly-Clark Corporation, Medline Industries, Inc., Paul Hartmann AG, Mölnlycke Health Care, Ahlstrom Corporation, Asahi Kasei Corporation, Medtronic, Inc., Svenska Cellulosa, Freudenberg & Co. KG, Aktiebolaget SCA, and Domtar Corporation.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/888

About Coherent Market Insights:

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name: Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US : +1-206-701-6702

UK : +44-020-8133-4027

JAPAN : +050-5539-1737

Duchenne Muscular Dystrophy (DMD) Treatment Market Opportunity Analysis-2026

Duchenne Muscular Dystrophy (DMD) Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration and weakness. DMD is caused due to alteration in gene sequence coding for dystrophin protein, which is present the muscle. It is a rare muscle disease which majorly affects males. The symptoms includes intellectual disability, muscle weakness and, difficulty in walking and breathing. Congestive heart failure, mental impairment, pneumonia or respiratory failure are some of the complications of this disease. The treatment is available to control or reduce the signs and symptoms as DMD is not curable. Steroid drugs are used to control the symptoms of duchenne muscular dystrophy. Stem cell therapy and gene therapy could be used for treatment of this disease in future.

Growing investments in the research and development, to find out effective treatment for DMD is driving the growth of duchenne muscular dystrophy (DMD) treatment market

According to the reports of Centers for Disease Control and prevention (CDC) 2007, 349 out of 2.37 million males in the United States were reported to be suffering from DMD. Whereas in 2019, 349 new cases of DMD were reported.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/898

Increasing incidences of DMD and requirement for its treatment is driving the growth of duchenne muscular dystrophy treatment market. Various organizations are involved in spreading awareness and investing in research and development to find the effective treatment for this disease, which is contributing to the growth of duchenne muscular dystrophy treatment market. For instance, Muscular Dystrophy Association (MDA), U.S. invests 75000 USD in research and development to find out the treatment for duchenne muscular dystrophy and the association funds more than 150 care centers, health care facility centers, and hospitals across U.S. and other countries. Moreover, other factors, such as constant research on stem cell therapy, gene therapy, and exon skipping drugs for the treatment of DMD is expected to propel the growth of DMD treatment market. However, major restraints hampering the growth of duchenne muscular dystrophy treatment market are, low seeking rate due to prognosis and late diagnosis of this disease.

Rising hospitalization for DMD is the factor helping the hospital segment to hold the maximum share in duchenne muscular dystrophy (DMD) treatment market

Growing patient population in North America and Europe is the factor contributing to the growth of duchenne muscular dystrophy (DMD) treatment market in these regions

Regional segmentation of Duchenne muscular dystrophy (DMD) treatment market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America dominates in the duchenne muscular dystrophy treatment market, due well-established healthcare facilities in this region.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/duchenne-muscular-dystrophy-treatment-market-898

Europe contributes to the growth of duchenne muscular dystrophy treatment market followed by North America, due to high rate of affected population in this region. For instance, according to Center for Disease Control and Prevention (CDC), in North England, 233 out of 1.49 million male patients were reported for DMD or other muscular dystrophy cases in 2009.

Key players are involved in the research and development of novel drug therapy for the treatment of duchenne muscular dystrophy (DMD)

Key players operating duchenne muscular dystrophy (DMD) treatment market includes SUMMIT Therapeutics Plc., PTC Therapeutics, BioMarin Pharmaceuticals Incorporated, Sarepta Therapeutics, Pfizer Incorporated, Pharmacia & Upjohn LLC, and others. Major industry players are involved in the research and development of novel drugs for treatment, and strategies such as collaboration and partnership are adopted by companies to hold the major share in the duchenne muscular dystrophy (DMD) treatment market. For instance, PTC Therapeutics International Limited has obtained conditional approval and orphan drug designation in 2014 for Translarna, which is a novel gene therapy for the treatment of duchenne muscular dystrophy.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/898

About Coherent Market Insights:

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name: Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US : +1-206-701-6702

UK : +44-020-8133-4027

JAPAN : +050-5539-1737

Wearable Sensor Market Size, Share, Outlook, and Opportunity Analysis, 2018– 2026

Health consciousness for fitness and advancement in technologies to make North America a global leader in Wearable Sensor Market

North America is leading the global Wearable Sensors Market and is expected to maintain its leading position during the forecast period. Adoption of innovative technologies and raising awareness for health and fitness in this region is expected to make North America a global leader in wearable sensors market. The favorable Food and Drug Administration (FDA) approval in sensor technologies makes wearable sensors market industry lucrative in North America. Europe is the second largest region for wearable sensors market. Europe is expected to lead wearable sensors market in near future, owing to high demand for wearable devices.

Wearable sensors are the devices that collect information about biological and physical properties of body and environment by the sensors present in wearable devices. This information is utilized further to measure the output information of body. Sensors are implemented in wearable devices to track environmental activities, such as temperature and weather information and to track fitness and health activities, such as body temperature, heart rate, stress level, heart pressure, blood pressure, movements, speed, and local temperature. Wearable sensors are used in devices, such as a smart-watch, smart shoes, body-wear, fitness watch, glasses, virtual reality headsets, sleep masks, and jewelry.

Technological advancement in sensing devices and introduction of key players into the market is expected to boost the growth of Wearable Sensors Market

The sensors device processes according to the surrounding environment and it is implemented on the wearable device to monitor body activities, which include, heart rate, body temperature, and blood pressure. Wearable sensors market is expected to show a significant growth over the forecast period, owing to the demand for wearable sensor devices in various applications such as healthcare, lifestyle, fitness, and security.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/905

Moreover, recent advancements in telecommunication, data analysis, sensor manufacturing, and microelectronics are providing opportunities for adoption of wearable sensors in the digital health environment. Additionally, in the healthcare industry, wearable sensors are used for monitoring patient’s conditions. These devices are also used in sports, military, and entertainment. For instance, Apple watch is a wearable device, which includes microphone, accelerometer, and a pulse sensor. Wearable sensors are integrated into garments, watches, eye-glasses, and smartphones, which is fueling the growth of the wearable sensor market.

Decreasing cost, attractive accessories, and integration with consumer electronic devices are the key factors for boosting the growth of global wearable device market. Additionally, introduction of key players in market such as Google, Amazon, Facebook, Apple, Microsoft, smartphone penetration in sensor technology, the high occurrence of chronic disease related to blood pressure and heart rate, geriatric population with cardiac and neurological disorders, fitness awareness, and reduced digital health-cost are anticipated to significantly drive the growth of global wearable sensors market.

Strong competition between manufacturers and safety concerns restrict the market growth

However, low consumer awareness and safety concerns for security data is a major restraint for growth of wearable sensor market. Moreover, lack of clarity for health communication protocol using wearable device and interoperability issues is expected to hinder the growth of market. Due to low-cost alternatives, intense competition is faced by key manufacturers, which is another factor hindering the growth of global wearable sensors market growth.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/wearable-sensor-market-905

Geographically, the wearable sensor market is segmented into North America, Europe, Asia Pacific, Middle East, Africa, and Latin America.

Asia Pacific region is anticipated to lead global market during the forecast period. Favorable reimbursement policies and advanced low-cost sensor systems are fueling the growth of wearable sensor market in Asia Pacific region.

Strategies of merger-acquisition by key players to expand the market growth

The major key players operating global wearable sensor market include Google, Panasonic Corporation, Freescale Semiconductor, Fossil Groups, InvenSense, Facebook, Amazon, Apple, Microsoft, Infineon Technologies AG, ST Microelectronics, and Analog Devices, Inc. These players are focused on developing business through strategies of merging-acquisition and product development to enhance the global growth. For instance, Facebook acquired Basis Science in March 2015, which specializes wearable sensor technology in wrist-watches. Moreover, Fossil Groups acquired Misfit in November 2015, to enhance their growth in global market.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/905

About Coherent Market Insights:

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name: Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US : +1-206-701-6702

UK : +44-020-8133-4027

JAPAN : +050-5539-1737

3D Printed Medical Implants Market Size Share Trends Forecast 2026

Rising need for medical implantation due to high prevalence of bone-dental disorders fuels the market growth in North America

North America holds the major share in the global 3D Printed Medical Implant Market and expected to retain the same position over the forecast period. U.S. accounts for a major share in 3D printing medical implantation market in North America. It is expected to remain the center for medical field development as it adopts new technological advancement to maintain the better health of individuals as well as economic position of the region. According to World Health organization (WHO), in 2016, around 65 million people suffered from bone-dental related disorders and around 18 million people met with road accidents. Thus, high prevalence of need for medical implantation, reduced costs of implantation procedures, and availability of expert surgeons in the U.S., accounted in the leading position of North America. Europe is expected to be the second largest market for the 3D printed medical implants over the forecast period. This is mainly due to the rising number of 3D printed medical implant manufacturers in the region. According to the World Health organization (WHO), in 2015, more than 12 million people suffered from bone-dental disorders in U.K. Increase in number of people suffering from dental-related disorders and increased rate of personal care, are some of factors driving the 3D printed medical implant market growth.

3D printing, also known as additive manufacturing, refers to addition of successive layers of raw material to produce objects forming three-dimensional file. In medical terms, 3D printed medical implants allow surgeons in surgery by implantation of biological objects, reduces risks involved during surgeries, decrease in anesthesia exposure duration, and risk of infection. 3D printing is a rapidly emerging technology which empowers key manufacturer in the medical field to form the customized medical products and implant them by replacing the damaged biological structure. 3D printed medical implantation allow patients in rapid recovery and thereby, it reduces hospital stay. Moreover, preclinical testing prior to implantation of 3D printed organs reduces chances of implant rejection.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/906

Increasing prevalence for the need of medical implant and Collaboration of manufacturers increases the demand for the market

According to the World Health Organization (WHO), in 2015, around 65 million people suffered with periodontitis in U.S. This is mainly owing to factors such as rising prevalence of periodontitis, diabetes-related gangrene, osteoarthritis, and peripheral vascular disease, which in turn, increases the use of 3D printed medical implants. Rapid technological advancement in the medical field is expected to witness growth in 3D printed medial Implants market during the forecast period. Moreover, increasing opportunity in biomedical applications and collaboration between manufacturing industries to increase product development has augmented the market growth. In addition, factors such as increased occurrence of chronic diseases such as bone-dental diseases and increase in number of accidents, expected to propel the 3D printed medical implant market growth over the forecast period.

However, critical reimbursement policies, the high cost of implanting and printing procedure, lack of technical expertise, and biocompatibility issues associated with medical implantation are some of the factors hindering the market growth.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/3d-printed-medical-implants-market-906

Geographically, the 3D printed medical implants market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East and Africa.

New product launch by key players to hold a global position throughout the global market

Some of the key players operating in the global 3D printed medical implants include 3D Systems Corporations, Stratasys Ltd, EnvisionTEC, Arcam AB, Organovo Holdings, Inc., EnvisionTEC, Arcam AB, SLM Solutions Group AG, Oxford Performance Materials, Inc., Materialise NV, Bio3D Technologies, and Cyfuse Medical K.K.

The key players are focusing on market strategies to expand their global market. New product launch and technological advancements to increase portability, energy efficiency, and cost efficiency for 3D printed medical implanting procedures and developing software for predicting the mechanical-thermal properties of the object are expected to enhance the scope for this market. For instance, Stratasys Ltd launched Objet30 Dental Prime in 2015, which is used for low-cost and high-quality medical implantation procedure.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/906

About Coherent Market Insights:

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name: Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US : +1-206-701-6702

UK : +44-020-8133-4027

JAPAN : +050-5539-1737

Rx Medical Food Market To Surpass US$ 30,757.3 Million By 2027 - Coherent Market Insights

Global Rx Medical Food Market, by Product Type (Pills, Powder, Liquid and Others (wafers, chewables, and bars)), by Therapeutic Application (Pain Management, Pain Management, Neurological Disorder, GI Disorder, Pulmonary Disorders, Metabolic Disorders, and Others (fibrosis, dialysis, AIDS, etc.)) by Distribution Channel (Retail Pharmacies and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 19,387.3 million in 2020 and is expected to exhibit a CAGR of 6.8 % during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

Medical nutrition is important for management of certain chronic conditions such as diabetes, obesity, constipation, malabsorption, indigestion, etc. It also helps to maintain healthy lifestyle, improve appetite and food intake, it lowers the risk of nutrient deficiencies and other health conditions.

Medical nutrition is recommended for patients of all ages including infants, adults, and geriatrics who are susceptible to conditions such as diabetes, obesity, renal failures, chronic diseases, neurological diseases, and others. These factors have led to an increase in demand for medical nutrition.

Manufacturers are focused on developing and launching medical food products with improved therapeutic effects and different dosage forms for ease of administration and patient convenience which is expected to drive growth of the Rx medical food market.

For instance, in March 2020, Conagen Inc., a biotechnology company, announced that it has developed a sustainable proprietary lactoferrin protein that mirrors the nutritional properties of lactoferrin from breast milk. In February 2020, Danone, a food-products corporation, launched the Aptamil baby formula pack with dual outer and inner QR codes for tracking and connecting services.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/909

Similarly, in April 2017, Abbott Laboratories launched science-based nutrition drinks such as Ensure Surgery Immunonutrition Shake and Ensure Pre Surgery Clear Nutrition, which are designed to support immune health, reduce insulin resistance, and fasten surgery recovery time.

In April 2017, Cambrooke Therapeutics Inc. launched Tylacti COMPLETE Bars, a nutritionally complete medical food for dietary management of Tyrosinemia (TYR). Furthermore, in September 2016, Cambrooke Therapeutics Inc. launched a new and improved Glytactin Complete Bar, a medical food for the dietary management of Phenylketonuria (PKU).

Rx Medical Food Market - Impact of Coronavirus (Covid-19) Pandemic

The coronavirus pandemic has negatively impacted the development, production, and supply of Rx medical food worldwide during the coronavirus pandemic. Many production and manufacturing facilities and transport departments have suspended operations at their Rx medical food factories to stop the spread of virus. Thus, this pandemic has affected both demand and supply of Rx medical food.

Since December 2019, a novel coronavirus spread throughout China and across the world, causing a continuous increase in confirmed cases within a short period of time. The disease has spread to more 100 countries around the globe with the World Health Organization declaring it a public health emergency.

For instance, according to the World Health Organization Coronavirus Disease (COVID-19) Dashboard (WHO) report, the manifestation of the coronavirus disease (COVID-19) has resulted in more than 11 million infected individuals worldwide as of July 2020.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/rx-medical-food-market-909

Following the spread of the coronavirus, several companies operating in the Rx medical food market are investing in development of new Rx medical food products to boost immunity in the body.

For instance, Danone’s nutrition health department, Nutricia is supporting research from independent medical professionals to define guidelines for nutritional care of COVID-19 patients recovering after intensive care unit (ICU) admittance.

In May 2020, Danone’s nutrition health department, Nutricia, announced that clinician-initiated research projects in 16 countries around the world will be supported by Nutricia with grants totaling around US$ 1.1 million.

Browse 35 Market Data Tables and 35 Figures spread through 228 Pages and in-depth TOC on Rx Medical Food Market, by Product Type (Pills, Powder, Liquid and Others (wafers, chewables, and bars)), by Therapeutic Application (Pain Management, Pain Management, Neurological Disorder, GI Disorder, Pulmonary Disorders, Metabolic Disorders and Others (fibrosis, dialysis, AIDS, etc.)) by Distribution Channel (Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Forecast to 2027"

Key Takeaways of the Rx Medical Food Market:

The global Rx medical food market is expected to exhibit a CAGR of 6.8% during the forecast period (2020-2027) owing to launch of Rx medical food products.

Among product type, the pills segment is expected to hold a major revenue share in 2027 owing to the increasing number of product launches. For instance, in June 2018, VAYA Pharma, Inc. expanded its medical food product offerings with the introduction of an extra-strength formula called Vayarin Plus, which caters to the clinical dietary management of ADHD (Attention-deficit/hyperactivity disorder) in adolescents as well as adults weighing more than 97 lbs.

Major players operating in the global Rx Medical Food Market are Abbott Laboratories, Danone S.A., Mead Johnson & Company, LLC, Fresenius Kabi AG, Nestle S.A., Primus Pharmaceuticals, Inc., Targeted Medical Pharma Inc., Pivotal Therapeutics Inc., VAYA Pharma, Inc., and AlfaSigma S.P.A.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/909

About Coherent Market Insights:

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name: Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US : +1-206-701-6702

UK : +44-020-8133-4027

JAPAN : +050-5539-1737

Monday, 29 March 2021

Anti-Snoring Treatment Market Size, Share, Outlook, and Opportunity Analysis, 2018– 2026

Anti-Snoring Treatment Market, By Surgery (Laser-Assisted Uvulopalatoplasty, Radiofrequency Ablation, Uvulopalatopharyngoplasty, Sclerotherapy, Pillar Procedure And Others), By Anti-Snoring Devices (Nasal Devices, Chin Straps, Oral Appliances, Position Control Devices, Tongue Stabilizing Devices And Others ), And By Geography- Global Industry Insights, Trends, Outlook, And Opportunity Analysis, 2018-2026

Snoring is the vibration of respiratory structures which results in sound while sleeping. It is a sleeping disorder caused due to monotonous narrowing and collapsing of the upper airway. Snoring have various adverse effects on health include coronary artery disease, systemic hypertension, atrial fibrillation, and stroke. Snoring is one of the factors of sleep deprivation, which may be further caused due to throat weakness, mispositioned jaw, obesity, and obstruction in the nasal passageway due to intake of alcohol and drugs. Snoring is a general phenomenon which can be treated or cured by use of anti-snoring devices or by nasal surgery. More than 300 devices are registered in the U.S. Patent and Trademark Office to cure snoring. However, surgery for the treatment of snoring include Laser-assisted uvulopalatoplasty, Uvulopalatopharyngoplasty, Radiofrequency ablation, sclerotherapy, Pillar procedure and others.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/926

High intake of alcohol and drugs is major cause of snoring, which is expected to augment the market growth

According to World Drug Report 2016, drug intake has reached epidemic levels with around 247 million drug users worldwide. Snoring is mainly caused due to intake of alcohol and drugs, which relax throat muscles. Moreover, increased consumption of alcohol by an individual for over a period of time causes respiratory tract blockage and also obesity is a major concern, leading to soring. According to World Health Organization (WHO), in 2014, around 1.9 billion adults were reported to have overweight, from which over 600 million adults were obese. Obesity is the second most common factor which results in snoring, it causes accumulation of fat around throat which causes increase in the prevalence of respiratory tract blockage. The removal of fat can be obtained by the laser-assisted surgeries, which in turn is expected to augment the market growth in the near future. Lack of knowledge about proper treatment and high cost of anti-snoring devices and surgeries are some of the factors restraining the anti-snoring treatment market growth.

Increasing prevalence of diabetes and alcohol consumption is expected to propel the market growth

Regional segmentation of the anti-snoring treatment market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold the dominant position in the anti-snoring treatment market, due to the increasing prevalence of snoring disorder in region.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/anti-snoring-treatment-market-926

According to American Sleep Foundation, in 2017, around 90 million American of all age group and genders are affected from one or the other respiratory disorder leading to snoring leading to increasing prevalence of snoring, expected to increase the demand for its treatment and hence fueling anti-snoring treatment market. Asia Pacific is expected to be the next dominant market, due to increasing obesity and respiratory disorders, leading to propel the growth of the anti-snoring treatment market over the forecast period.

Market Players

Some of the major players operating in the global anti-snoring treatment market include GlaxoSmithKline, plc, Apnea Sciences Corporation, Fisher & Paykel Healthcare, Sleeping Well, LLC, Sleep Well Enjoy Life, Ltd., AccuMED Corp., ResMed, Inc., and Airing CPAP.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/926

About Coherent Market Insights:

Contact Us:

mailto:sales@coherentmarketinsights.com

U.S. Office:

Name: Mr. Shah

Coherent Market Insights 1001 4th Ave,

# 3200 Seattle, WA 98154, U.S.

US : +1-206-701-6702

UK : +44-020-8133-4027

JAPAN : +050-5539-1737